[SARS-CoV infection and pregnancy].
Identifieur interne : 002F62 ( Main/Exploration ); précédent : 002F61; suivant : 002F63[SARS-CoV infection and pregnancy].
Auteurs : Kinga Ksiezakowska ; Magdalena Laszczyk ; Jan Wilczy Ski ; Dorota NowakowskaSource :
- Ginekologia polska [ 0017-0011 ] ; 2008.
Descripteurs français
- KwdFr :
- Complications de la grossesse et maladies infectieuses (), Complications de la grossesse et maladies infectieuses (diagnostic), Diagnostic différentiel, Facteurs de risque, Femelle, Grossesse, Humains, Issue de la grossesse, Nouveau-né, Retard de croissance intra-utérin (virologie), Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (transmission), Transmission verticale de maladie infectieuse (), Virus du SRAS (isolement et purification).
- MESH :
- diagnostic : Complications de la grossesse et maladies infectieuses, Syndrome respiratoire aigu sévère.
- isolement et purification : Virus du SRAS.
- virologie : Retard de croissance intra-utérin.
- Complications de la grossesse et maladies infectieuses, Diagnostic différentiel, Facteurs de risque, Femelle, Grossesse, Humains, Issue de la grossesse, Nouveau-né, Syndrome respiratoire aigu sévère, Transmission verticale de maladie infectieuse.
English descriptors
- KwdEn :
- Diagnosis, Differential, Female, Fetal Growth Retardation (virology), Humans, Infant, Newborn, Infectious Disease Transmission, Vertical (prevention & control), Pregnancy, Pregnancy Complications, Infectious (diagnosis), Pregnancy Complications, Infectious (therapy), Pregnancy Outcome, Risk Factors, SARS Virus (isolation & purification), Severe Acute Respiratory Syndrome (complications), Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (therapy), Severe Acute Respiratory Syndrome (transmission).
- MESH :
- complications : Severe Acute Respiratory Syndrome.
- diagnosis : Pregnancy Complications, Infectious, Severe Acute Respiratory Syndrome.
- isolation & purification : SARS Virus.
- prevention & control : Infectious Disease Transmission, Vertical.
- therapy : Pregnancy Complications, Infectious, Severe Acute Respiratory Syndrome.
- transmission : Severe Acute Respiratory Syndrome.
- virology : Fetal Growth Retardation.
- Diagnosis, Differential, Female, Humans, Infant, Newborn, Pregnancy, Pregnancy Outcome, Risk Factors.
Abstract
SARS is a highly contagious infection, caused by new coronavirus SARS-CoV. Immunopathological mechanisms responsible for the reaction to SARS-CoV infection have not yet been fully elucidated. Cytokine profile of SARS patients showed marked elevation of Th1 cytokine, interferon gamma, inflammatory cytokines for at least 2 weeks after the onset of the disease. The clinical manifestation of SARS in patients has been of varied nature. Fever of more then 38 degrees C, lasting more then 24 hours, is the most frequently encountered symptom. Other symptoms are non specific and they may include: sore throat, myalgia and nausea. The results of the radiological investigation may appear normal. Infants born to pregnant women with SARS did not appear to have acquired the infection through vertical transmission. However, direct contact with the maternal body fluid which contained SARS-CoV, has put the infants in great danger of perinatal infection. Ribavirin and corticosteroids are usually suggested for the treatment of SARS. However, the ribavirin therapy increases the risk of teratogenic effects in newborns of pregnant women with SARS. Therefore, the usage of this drug is not recommended during pregnancy and lactation.
PubMed: 18510050
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001B29
- to stream PubMed, to step Curation: 001B29
- to stream PubMed, to step Checkpoint: 001960
- to stream Ncbi, to step Merge: 001C71
- to stream Ncbi, to step Curation: 001C71
- to stream Ncbi, to step Checkpoint: 001C71
- to stream Main, to step Merge: 003026
- to stream Main, to step Curation: 002F62
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[SARS-CoV infection and pregnancy].</title>
<author><name sortKey="Ksiezakowska, Kinga" sort="Ksiezakowska, Kinga" uniqKey="Ksiezakowska K" first="Kinga" last="Ksiezakowska">Kinga Ksiezakowska</name>
<affiliation><nlm:affiliation>Studenckie Koło Naukowe przy Klinice Medycyny Matczyno-Płodowej i Ginekologii (KMMPiG), III Katedry Połoznictwa i Ginekologii (III KPiG), Uniwersytetu Medycznego (UM) w Łodzi.</nlm:affiliation>
<wicri:noCountry code="subField">Uniwersytetu Medycznego (UM) w Łodzi</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Laszczyk, Magdalena" sort="Laszczyk, Magdalena" uniqKey="Laszczyk M" first="Magdalena" last="Laszczyk">Magdalena Laszczyk</name>
</author>
<author><name sortKey="Wilczy Ski, Jan" sort="Wilczy Ski, Jan" uniqKey="Wilczy Ski J" first="Jan" last="Wilczy Ski">Jan Wilczy Ski</name>
</author>
<author><name sortKey="Nowakowska, Dorota" sort="Nowakowska, Dorota" uniqKey="Nowakowska D" first="Dorota" last="Nowakowska">Dorota Nowakowska</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18510050</idno>
<idno type="pmid">18510050</idno>
<idno type="wicri:Area/PubMed/Corpus">001B29</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B29</idno>
<idno type="wicri:Area/PubMed/Curation">001B29</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B29</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001960</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001960</idno>
<idno type="wicri:Area/Ncbi/Merge">001C71</idno>
<idno type="wicri:Area/Ncbi/Curation">001C71</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001C71</idno>
<idno type="wicri:doubleKey">0017-0011:2008:Ksiezakowska K:sars:cov:infection</idno>
<idno type="wicri:Area/Main/Merge">003026</idno>
<idno type="wicri:Area/Main/Curation">002F62</idno>
<idno type="wicri:Area/Main/Exploration">002F62</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[SARS-CoV infection and pregnancy].</title>
<author><name sortKey="Ksiezakowska, Kinga" sort="Ksiezakowska, Kinga" uniqKey="Ksiezakowska K" first="Kinga" last="Ksiezakowska">Kinga Ksiezakowska</name>
<affiliation><nlm:affiliation>Studenckie Koło Naukowe przy Klinice Medycyny Matczyno-Płodowej i Ginekologii (KMMPiG), III Katedry Połoznictwa i Ginekologii (III KPiG), Uniwersytetu Medycznego (UM) w Łodzi.</nlm:affiliation>
<wicri:noCountry code="subField">Uniwersytetu Medycznego (UM) w Łodzi</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Laszczyk, Magdalena" sort="Laszczyk, Magdalena" uniqKey="Laszczyk M" first="Magdalena" last="Laszczyk">Magdalena Laszczyk</name>
</author>
<author><name sortKey="Wilczy Ski, Jan" sort="Wilczy Ski, Jan" uniqKey="Wilczy Ski J" first="Jan" last="Wilczy Ski">Jan Wilczy Ski</name>
</author>
<author><name sortKey="Nowakowska, Dorota" sort="Nowakowska, Dorota" uniqKey="Nowakowska D" first="Dorota" last="Nowakowska">Dorota Nowakowska</name>
</author>
</analytic>
<series><title level="j">Ginekologia polska</title>
<idno type="ISSN">0017-0011</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Diagnosis, Differential</term>
<term>Female</term>
<term>Fetal Growth Retardation (virology)</term>
<term>Humans</term>
<term>Infant, Newborn</term>
<term>Infectious Disease Transmission, Vertical (prevention & control)</term>
<term>Pregnancy</term>
<term>Pregnancy Complications, Infectious (diagnosis)</term>
<term>Pregnancy Complications, Infectious (therapy)</term>
<term>Pregnancy Outcome</term>
<term>Risk Factors</term>
<term>SARS Virus (isolation & purification)</term>
<term>Severe Acute Respiratory Syndrome (complications)</term>
<term>Severe Acute Respiratory Syndrome (diagnosis)</term>
<term>Severe Acute Respiratory Syndrome (therapy)</term>
<term>Severe Acute Respiratory Syndrome (transmission)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses ()</term>
<term>Complications de la grossesse et maladies infectieuses (diagnostic)</term>
<term>Diagnostic différentiel</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Issue de la grossesse</term>
<term>Nouveau-né</term>
<term>Retard de croissance intra-utérin (virologie)</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Syndrome respiratoire aigu sévère (diagnostic)</term>
<term>Syndrome respiratoire aigu sévère (transmission)</term>
<term>Transmission verticale de maladie infectieuse ()</term>
<term>Virus du SRAS (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Pregnancy Complications, Infectious</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Infectious Disease Transmission, Vertical</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Pregnancy Complications, Infectious</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Retard de croissance intra-utérin</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Fetal Growth Retardation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term>
<term>Female</term>
<term>Humans</term>
<term>Infant, Newborn</term>
<term>Pregnancy</term>
<term>Pregnancy Outcome</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses</term>
<term>Diagnostic différentiel</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Issue de la grossesse</term>
<term>Nouveau-né</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Transmission verticale de maladie infectieuse</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">SARS is a highly contagious infection, caused by new coronavirus SARS-CoV. Immunopathological mechanisms responsible for the reaction to SARS-CoV infection have not yet been fully elucidated. Cytokine profile of SARS patients showed marked elevation of Th1 cytokine, interferon gamma, inflammatory cytokines for at least 2 weeks after the onset of the disease. The clinical manifestation of SARS in patients has been of varied nature. Fever of more then 38 degrees C, lasting more then 24 hours, is the most frequently encountered symptom. Other symptoms are non specific and they may include: sore throat, myalgia and nausea. The results of the radiological investigation may appear normal. Infants born to pregnant women with SARS did not appear to have acquired the infection through vertical transmission. However, direct contact with the maternal body fluid which contained SARS-CoV, has put the infants in great danger of perinatal infection. Ribavirin and corticosteroids are usually suggested for the treatment of SARS. However, the ribavirin therapy increases the risk of teratogenic effects in newborns of pregnant women with SARS. Therefore, the usage of this drug is not recommended during pregnancy and lactation.</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Ksiezakowska, Kinga" sort="Ksiezakowska, Kinga" uniqKey="Ksiezakowska K" first="Kinga" last="Ksiezakowska">Kinga Ksiezakowska</name>
<name sortKey="Laszczyk, Magdalena" sort="Laszczyk, Magdalena" uniqKey="Laszczyk M" first="Magdalena" last="Laszczyk">Magdalena Laszczyk</name>
<name sortKey="Nowakowska, Dorota" sort="Nowakowska, Dorota" uniqKey="Nowakowska D" first="Dorota" last="Nowakowska">Dorota Nowakowska</name>
<name sortKey="Wilczy Ski, Jan" sort="Wilczy Ski, Jan" uniqKey="Wilczy Ski J" first="Jan" last="Wilczy Ski">Jan Wilczy Ski</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F62 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002F62 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:18510050 |texte= [SARS-CoV infection and pregnancy]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18510050" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |